Signal Transduction Therapy Targeting Apoptosis Pathways in Cancers
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
179-190
Author(s):
Simone Fulda and Klaus-Michael Debatin
T-Cell Zeta Chain Expression, Phosphorylation and Degradation and their Role in T-Cell Signal Transduction and Immune Response Regulation in Health And Disease
Journal:
Current Signal Transduction Therapy
Volume:
1
Page:
191-208
Author(s):
Theodoros Eleftheriadis, Georgia Antoniadi, Vassilios Liakopoulos and Alexandros Kortsaris
Review: Recent Clinical Trials in Epigenetic Therapy
Journal:
Reviews on Recent Clinical Trials
Volume:
1
Page:
169-182
Author(s):
Yasuhiro Oki and Jean-Pierre J. Issa
Immuno-Isolation in Cancer Gene Therapy
Journal:
Current Gene Therapy
Volume:
6
Page:
181-191
Author(s):
Pasquale Cirone, Murray Potter, Hal Hirte and Patricia Chang
Peripheral Neuropathy Induced by Paclitaxel: Recent Insights and Future Perspectives
Journal:
Current Neuropharmacology
Volume:
4
Page:
165-172
Author(s):
Charity D. Scripture, William D. Figg and Alex Sparreboom
Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Journal:
Current Drug Targets
Volume:
7
Page:
423-442
Author(s):
Dominique Delmas, Allan Lancon, Didier Colin, Brigitte Jannin and Norbert Latruffe
Histone Deacetylases as Targets for Dietary Cancer Preventive Agents: Lessons Learned with Butyrate, Diallyl Disulfide, and Sulforaphane
Journal:
Current Drug Targets
Volume:
7
Page:
443-452
Author(s):
Melinda C. Myzak and Roderick H. Dashwood
Destroying RNA as a Therapeutic Approach
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
863-881
Author(s):
Alaeddin Tafech, Tyler Bassett, Dan Sparanese and Chow H. Lee
Ruthenium Complexes as Anticancer Agents
Journal:
Current Medicinal Chemistry
Volume:
13
Page:
1085-1107
Author(s):
Irena Kostova
Predicting Type-I (Rate-Shift) Functional Divergence of Protein Sequences and Applications in Functional Genomics
Journal:
Current Genomics
Volume:
7
Page:
87-96
Author(s):
Xun Gu, Yufeng Wang, Jianying Gu, Kent V. Velden and Dongping Xu